An open source multistep model to predict mutagenicity from statistical analysis and relevant structural alerts

Thomas Ferrari1, Giuseppina Gini

  • 1Department of Electronics and Information (DEI), Politecnico di Milano via Ponzio, 34/5 - 20133 Milano, Italy. tferrari@elet.polimi.it

Abstract

Insights

A new cascade model predicts Salmonella mutagenicity with 85% accuracy, matching the Ames test. This computational approach offers a faster, cheaper alternative for assessing genetic mutation risks.

Area of Science:

  • Computational toxicology
  • cheminformatics
  • Predictive modeling

Background:

  • Mutagenicity, the ability to cause genetic mutations, is linked to carcinogenicity and reproductive toxicity.
  • The experimental Ames test has 85% reproducibility, necessitating faster and cheaper alternatives.
  • In silico structure-activity relationship (SAR) models offer a promising alternative for mutagenicity assessment.

Purpose of the Study:

  • To develop and validate a cascade model for predicting Salmonella mutagenicity.
  • To improve upon existing methods by reducing false negatives and enhancing prediction accuracy.
  • To provide a reliable in silico tool for mutagenicity assessment.

Main Methods:

  • Development of a cascade model integrating statistical prediction and structural alert analysis.
  • Validation on a large public dataset of molecular structures and their mutagenicity outcomes.
  • Statistical modeling followed by targeted checks for structural alerts in predicted safe compounds.

Main Results:

  • The developed cascade model achieved prediction accuracy approaching the 85% reproducibility of the experimental Ames test.
  • The model effectively combines statistical predictions with structural alert analysis for improved accuracy.
  • Validation demonstrated the model's capability in correctly classifying both positive and negative mutagenicity outcomes.

Conclusions:

  • The developed computational model provides a reliable method for predicting Salmonella mutagenicity.
  • The model and its documentation are publicly available on the CAESAR website for regulatory and research use.
  • The system accepts molecular structures as input and provides a classification result, facilitating efficient risk assessment.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.